MiMedx Group Investor Relations Material
Latest events
Q2 2025
MiMedx Group
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from MiMedx Group Inc
Access all reports
MiMedx Group Inc. is a biopharmaceutical company specializing in regenerative medicine. The company develops and markets advanced products derived from human placental tissue to support wound healing and tissue repair. MiMedx’s solutions are used in areas such as chronic wound care, surgical applications, and musculoskeletal conditions. The company is headquartered in Marietta, Georgia, and its shares are listed on the NASDAQ.
Key slides for MiMedx Group Inc
Investor Presentation
MiMedx Group Inc
Investor Presentation
MiMedx Group Inc
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
MDXG
Country
🇺🇸 United States